Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
6(75%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
25%
Ph not_applicable
1
13%
Ph phase_2
3
38%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

8

all time

Status Distribution
Active(7)
Completed(1)

Detailed Status

Recruiting4
Active, not recruiting2
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (50.0%)
Phase 32 (33.3%)
N/A1 (16.7%)

Trials by Status

not_yet_recruiting113%
recruiting450%
active_not_recruiting225%
completed113%

Recent Activity

6 active trials
Showing 5 of 8
recruitingphase_2

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

NCT07173972
active_not_recruitingphase_3

Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study

NCT07306663
recruitingphase_2

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

NCT07248956
active_not_recruitingphase_2

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

NCT06139419
recruiting

Safety and Efficacy of IMPT or IMRT for Breast Cancer

NCT06826885
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07173972Phase 2

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

Recruiting
NCT07306663Phase 3

Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study

Active Not Recruiting
NCT07248956Phase 2

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Recruiting
NCT06139419Phase 2

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

Active Not Recruiting
NCT06826885

Safety and Efficacy of IMPT or IMRT for Breast Cancer

Recruiting
NCT05062005Phase 3

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Recruiting
NCT03367884Not Applicable

Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer

Not Yet Recruiting
NCT00351598

Lung Tumour Volume Database

Completed

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8